Renaissance Technologies - ATHIRA PHARMA INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$571
-55.9%
282,900
-35.5%
0.00%
-50.0%
Q2 2023$1,294
+65.9%
438,800
+40.7%
0.00%
+100.0%
Q1 2023$780
+200.0%
311,865
+279.9%
0.00%
Q4 2022$260
-100.0%
82,100
-65.1%
0.00%
-100.0%
Q3 2022$698,000
+38.2%
235,003
+528.4%
0.00%0.0%
Q1 2022$505,000
-65.9%
37,400
-67.1%
0.00%
-50.0%
Q4 2021$1,483,000
+199.6%
113,800
+115.8%
0.00%
+100.0%
Q3 2021$495,00052,7330.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Logos Global Management LP 1,630,744$21,249,0002.19%
VR Adviser, LLC 1,000,000$13,030,0001.78%
ACUTA CAPITAL PARTNERS, LLC 310,030$4,040,0001.70%
Ikarian Capital, LLC 860,000$11,207,0001.67%
Bristlecone Advisors, LLC 761,563$9,923,0001.19%
Perceptive Advisors 6,851,832$89,280,0000.69%
DAFNA Capital Management LLC 160,983$2,098,0000.53%
PATHSTONE FAMILY OFFICE, LLC 1,442,247$18,792,0000.47%
Potomac Capital Management, Inc. 40,000$521,0000.46%
RTW INVESTMENTS, LP 1,906,557$24,842,0000.36%
View complete list of ATHIRA PHARMA INC shareholders